¿Cómo se comparó el EPS reciente de KONEF con las expectativas?
¿Cómo fue el desempeño de los ingresos de Wellbeing Digital Sciences Inc KONEF en el último trimestre?
¿Cuál es la estimación de ingresos para Wellbeing Digital Sciences Inc?
¿Cuál es la puntuación de calidad de ganancias de Wellbeing Digital Sciences Inc?
¿Cuándo informa Wellbeing Digital Sciences Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Wellbeing Digital Sciences Inc?
¿Superó Wellbeing Digital Sciences Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0
Precio de apertura
$0
Rango del día
$0 - $0
Rango de 52 semanas
$0 - $0
Volumen
360
Volumen promedio
0
EPS (TTM)
-0.21
Rendimiento de dividendos
--
Cap. de mercado
$1.2K
¿Qué es KONEF?
Wellbeing Digital Sciences, Inc. is a healthcare company, which engages in the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company is headquartered in London, Ontario. The company went IPO on 2021-01-27. The firm is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. The company operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. The company is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.